Anti-inflammatory Effect of BQ-123 in Atherosclerosis

李月华,冯月英,徐琛华,刘晓红,姜坚,陈书艳
2009-01-01
Abstract:Objective To observe the anti-inflammatory effect of endothelin receptor A(ETA)antagonist BQ-123 in rabbits with atherosclerosis.Methods Tirty-two male New Zealand white rabbits were randomly divided into 4 groups:control,model,simvastatin,and BQ-123 treatment groups(n=8).Rabbits in control group were fed with standard diet for 10 weeks,and the other rabbits were fed with high-fat diet for 10 weeks.Peripheral blood of the rabbits was collected from ear artery for determination of the levels of endothelin-1(ET-1)and prostaglandin E2(PGE2)in serum with ELISA.SP immunohistochemical staining was used to detect the expressions of ET-1,macrophage and COX-2 protein in the aorta.Results ① After 10-week feeding,the levels of ET-1 and PGE2 in serum in model,simvastatin,and BQ-123 groups were significantly higher than those in control group(P0.01).However,those in simvastatin and BQ-123 groups were significantly lower than those in model group(P0.05,P0.01).The level of ET-1 in rabbits with atherosclerosis was related to that of PGE2(r=0.57,P0.01).②Compared with model group,the positive expressions of ET-1,macrophage-derived foam cells and COX-2 protein in simvastatin and BQ-123 groups were significantly lower(P0.05,P0.01),and the positive expressions in BQ-123 group had a further decrease compared with simvastatin group(P0.05).Conclusion ETA activated by ET-1 up-regulates the expression of COX-2 protein and production of PGE2 in plaque in rabbits with atherosclerosis.Selective ETA antagonist BQ-123 has potent anti-inflammatory effect in rabbits with atherosclerosis.
What problem does this paper attempt to address?